Glucagon deficiency as a possible cause of persistent neonatal hypoglycaemia has been discussed before (Wagner et al., 1969; Gotlin and Silver, 1970; Zuppinger, 1975) . Vidnes (1976) recently described a case of persistent hereditary neonatal hypoglycaemia due to glucagon deficiency; therapy with zinc-protamine-glucagon resulted in dramatic improvement. This was the first case in a child where glucagon deficiency was verified by glucagon determination. We here describe a further case of a newborn infant with persistent neonatal hypoglycaemia due to glucagon deficiency and treated by zinc-protamine-glucagon.
Case report
A boy was born after a normal pregnancy in August 1975 as the third child of healthy unrelated parents. He has 2 healthy siblings. No family history of infant deaths from hypoglycaemia was known.
Birthweight was 3-7 kg. The child was breast fed, and the first day passed uneventfully. In the evening of the second day he became drowsy and failed to suck. Next morning he was apathetic, breathed irregularly, and rolled his eyes. At admission to a local hospital blood glucose was low (0.9 mmol/l; 16 mg/100 ml) with a metabolic acidosis (pH 7-22, base excess -5 5 mmol/l (-5.5 mEq/l)). Treatment was started with infusion of glucose 10%; after 2 and 4 hours respectively the blood glucose value was 1 *6 and 0.5 mmol/l (28.8, 9 mg/100 ml). Apart from the infusion therapy, which was continued, he received feeds of humanised milk, and prednisone was started. The first day after admission several convulsions were noted, but within a few days the clinical condition improved. During the next few weeks several attempts were made to reduce the frequency of oral feedings below 8 times per day, but each time the blood glucose level decreased and his condition deteriorated.
At the age of 3 weeks he was referred to the University Hospital. We found an alert but sweaty and restless baby with a length of 56*5 cm and a weight of 4250 g. The liver was palpable 1 cm below the costal margin. Blood was analysed for cortisol, insulin, thyroxine, growth hormone, lactate, pyruvate, and alanine levels. After 2 hours of fasting the levels of f-hydroxybutyrate and acetoacetate were respectively 37 and 15 Vmol/l (0O 39,0*15 mg/100 ml).
Reducing substances in the urine were absent. Vanillylmandelic acid excretion was 4.5 nmol in 24 hours. No abnormal organic acids in the urine were detected by gas chromatography. Under a regimen of 12 oral feeds of humanised milk per day, blood glucose varied between 1 -8 and 3.0 mmol/l (32, 54 mg/100 ml). A glucose tolerance test showed a high peak value after 45 minutes and rapid decrease to values below normal. Insulin regulation during the test was normal (Zuppinger, 1975; Fig. 1) . A glucagon tolerance test showed a normal glucose mobilisation, followed by rapid decrease to values below normal: again insulin regulation was intact (Zuppinger, 1975;  Fig. 2 ).
In the light of a possible glucagon deficiency we started treatment with zinc-protamine-glucagon IM at a dose of 2 mg, with 8 feeds per day. For 8-10 hours after the injection the blood glucose level remained above 3 mmol/l (54 mg/100 ml). When given twice daily, the effect lasted for 24 hours.
The clinical condition improved, and the frequency of feeds could be lowered to 6 times per day. In the next few months we had to increase the dosage of glucagon gradually, and stable glucose values could then be maintained. With a regimen of 6 feeds per day and two daily doses of 3.5 mg glucagon IM symptomatic hypoglycaemia did not occur. The patient was discharged in December 1975. After some months the parents discontinued the glucagon (Table) varied between 6 and 15 ,uU/ml, while glucagon values were below 10 ng/l. , 1950; Wagner et al., 1969; Gotlin and Silver, 1970) . In Vidnes's (1976) case of persistent neonatal hypoglycaemia due to glucagon deficiency, verified by measuring plasma, treatment with zinc-protamineglucagon was successful: after 2 months the dosage of glucagon had to be gradually increased as in our case, probably because of antibody production. Neonatal hypoglycaemia due to glucagon deficiency may be extremely dangerous for the neonate. During glucose need it is glucagon, through a mechanism that remains to be elucidated, that converts the liver to a 'ketogenic mode' and thereby maintains a level of hepatic ketone production necessary to meet cerebral fuel needs (Unger and Orci, 1976) . The ketones are an important alternate substrate for the neonatal brain. Ketogenesis in our patient was not adequately studied because the fasting period was limited.
Summary
In a newborn baby, suffering from persistent severe hypoglycaemia with convulsions glucagon deficiency was shown. Treatment with zinc-protamine-glucagon injection twice daily resulted in normal blood glucose levels. Motor development is delayed.
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